SHH:688336
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd · SHH · Healthcare · CNY · FY for 2025
Figures on this page computed 2026-11-08 13:04 UTC
Last close
n/aCNY
Market data
7.1xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
69.0%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
66.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.4%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
Five bars, one line
lens 7 of 9Each against its own average
3 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales3.18x
Its own average over 10 years, 1.32B.
- Profit5.79x
Its own average over 10 years, 500.4M.
- Free cash flow8.32x
Its own average over 10 years, 335.3M.
- Debtn/a
Its own average over 3 years, 83.4M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 8.32 times.
Sales is 3.18 times its own 10-year average; Profit is 5.79 times its own 10-year average; Free cash flow is 8.32 times its own 10-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales against its own 10-year average3.18
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Profit against its own 10-year average5.79
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Free cash flow against its own 10-year average8.32
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Debt against its own 3-year averagen/a
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- CNY